Phosphorylation, lipid raft interaction and traffic of α-synuclein in a yeast model for Parkinson

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 10, 2008, Pages 1767-1780

  Zabrocki, Piotr ^a   Bastiaens, Ilse ^a   Delay, Charlotte ^a   Bammens, Tine ^a   Ghillebert, Ruben ^a   Pellens, Klaartje ^a   De Virgilio, Claudio ^c   Van Leuven, Fred ^b   Winderickx, Joris ^a  

^a Laboratory of Developmental Biology   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Synuclein; Casein kinase; Endocytosis; Lipid raft; N terminal acetyltransferase; Parkinson's disease; Vesicular recycling; Vesicular trafficking; Yeast

Indexed keywords

ACYLTRANSFERASE; ALPHA SYNUCLEIN; CASEIN KINASE I; CASEIN KINASE II; ERGOSTEROL;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; CYTOTOXICITY; DEGENERATIVE DISEASE; DELETION MUTANT; DISEASE MODEL; ENDOCYTOSIS; LIPID RAFT; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; YEAST;

ALPHA-SYNUCLEIN; CASEIN KINASES; ERGOSTEROL; MEMBRANE MICRODOMAINS; MODELS, BIOLOGICAL; MUTATION; PARKINSON DISEASE; PHOSPHORYLATION; PROTEIN TRANSPORT; SACCHAROMYCES CEREVISIAE; SUBSTRATE SPECIFICITY;

EID: 50849130565     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.06.010     Document Type: Article

References (92)

1. Tofaris G.K., and Spillantini M.G. Alpha-synuclein dysfunction in Lewy body diseases. Mov. Disord. 12 20 Suppl (2005) S37-S44
2. Hardy J., Cai H., Cookson M.R., Gwinn-Hardy K., and Singleton A. Genetics of Parkinson's disease and parkinsonism. Ann. Neurol. 60 (2006) 389-398
3. Sidhu A., Wersinger C., and Vernier P. Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?. FASEB J. 18 (2004) 637-647
4. Chandra S., Gallardo G., Fernandez-Chacon R., Schluter O.M., and Sudhof T.C. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123 (2005) 383-396
5. Larsen K.E., Schmitz Y., Troyer M.D., Mosharov E., Dietrich P., Quazi A.Z., Savalle M., Nemani V., Chaudhry F.A., Edwards R.H., Stefanis L., and Sulzer D. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 26 (2006) 11915-11922
6. Outeiro T.F., and Lindquist S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302 (2003) 1772-1775
7. Zabrocki P., Pellens K., Vanhelmont T., Vandebroek T., Griffioen G., Wera S., Van Leuven F., and Winderickx J. Characterization of alpha-synuclein aggregation and synergistic toxicity with protein tau in yeast. FEBS J. 272 (2005) 1386-1400
8. Dixon C., Mathias N., Zweig R.M., Davis D.A., and Gross D.S. Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast. Genetics 170 (2005) 47-59
9. Cooper A.A., Gitler A.D., Cashikar A., Haynes C.M., Hill K.J., Bhullar B., Liu K., Xu K., Strathearn K.E., Liu F., Cao S., Caldwell K.A., Caldwell G.A., Marsischky G., Kolodner R.D., Labaer J., Rochet J.C., Bonini N.M., and Lindquist S. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313 (2006) 324-328
10. Willingham S., Outeiro T.F., DeVit M.J., Lindquist S.L., and Muchowski P.J. Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science 302 (2003) 1769-1772
11. Brachmann C.B., Davies A., Cost G.J., Caputo E., Li J., Hieter P., and Boeke J.D. Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 14 (1998) 115-132
12. Gietz D., St Jean A., Woods R.A., and Schiestl R.H. Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 20 (1992) 1425
13. Tong A.H., Evangelista M., Parsons A.B., Xu H., Bader G.D., Page N., Robinson M., Raghibizadeh S., Hogue C.W., Bussey H., Andrews B., Tyers M., and Boone C. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science 294 (2001) 2364-2368
14. Bagnat M., Keranen S., Shevchenko A., and Simons K. Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc. Natl. Acad. Sci. U. S.A. 97 (2000) 3254-3259
15. Soper J.H., Roy S., Stieber A., Lee E., Wilson R.B., Trojanowski J.Q., Burd C.G., and Lee V.M. a-Synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol. Biol. Cell 19 (2008) 1093-1103
16. Wood-Kaczmar A., Gandhi S., and Wood N.W. Understanding the molecular causes of Parkinson's disease. Trends Mol. Med. 12 (2006) 521-528
17. Chen Q., Thorpe J., and Keller J.N. Alpha-synuclein alters proteasome function, protein synthesis, and stationary phase viability. J. Biol. Chem. 280 (2005) 30009-30017
18. Flower T.R., Chesnokova L.S., Froelich C.A., Dixon C., and Witt S.N. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. J. Mol. Biol. 351 (2005) 1081-1100
19. Griffioen G., Duhamel H., Van Damme N., Pellens K., Zabrocki P., Pannecouque C., van Leuven F., Winderickx J., and Wera S. A yeast-based model of alpha-synucleinopathy identifies compounds with therapeutic potential. Biochim. Biophys. Acta 1762 (2006) 312-318
20. Sharma N., Brandis K.A., Herrera S.K., Johnson B.E., Vaidya T., Shrestha R., and Debburman S.K. alpha-Synuclein budding yeast model: toxicity enhanced by impaired proteasome and oxidative stress. J. Mol. Neurosci. 28 (2006) 161-178
21. Winderickx J., Delay C., De Vos A., Klinger H., Pellens K., Vanhelmont T., Van Leuven F., and Zabrocki P. Protein folding diseases and neurodegeneration: lessons learned from yeast. Biochim. Biophys. Acta (2008)
22. Gietz R.D., Graham K.C., and Litchfield D.W. Interactions between the subunits of casein kinase II. J. Biol. Chem. 270 (1995) 13017-13021
23. Kobayashi S.D., and Nagiec M.M. Ceramide/long-chain base phosphate rheostat in Saccharomyces cerevisiae: regulation of ceramide synthesis by Elo3p and Cka2p. Eukaryot. Cell 2 (2003) 284-294
24. Chang Y.F., and Carman G.M. Casein kinase II phosphorylation of the yeast phospholipid synthesis transcription factor Opi1p. J. Biol. Chem. 281 (2006) 4754-4761
25. Ahmed K., Gerber D.A., and Cochet C. Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol. 12 (2002) 226-230
26. Seeley E.S., Kato M., Margolis N., Wickner W., and Eitzen G. Genomic analysis of homotypic vacuole fusion. Mol. Biol. Cell 13 (2002) 782-794
27. LaGrassa T.J., and Ungermann C. The vacuolar kinase Yck3 maintains organelle fragmentation by regulating the HOPS tethering complex. J. Cell Biol. 168 (2005) 401-414
28. Takeda K., Cabrera M., Rohde J., Bausch D., Jensen O.N., and Ungermann C. The vacuolar V(1)/V(0)-ATPase is involved in the release of the HOPS subunit Vps41 from vacuoles, vacuole fragmentation and fusion. FEBS Lett. 582 (2008) 1558-1563
29. Feng Y., and Davis N.G. Akr1p and the type I casein kinases act prior to the ubiquitination step of yeast endocytosis: Akr1p is required for kinase localization to the plasma membrane. Mol. Cell Biol. 20 (2000) 5350-5359
30. Okochi M., Walter J., Koyama A., Nakajo S., Baba M., Iwatsubo T., Meijer L., Kahle P.J., and Haass C. Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J. Biol. Chem. 275 (2000) 390-397
31. Wakamatsu M., Ishii A., Ukai Y., Sakagami J., Iwata S., Ono M., Matsumoto K., Nakamura A., Tada N., Kobayashi K., Iwatsubo T., and Yoshimoto M. Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein. J. Neurosci. Res. 85 (2007) 1819-1825
32. Jo E., Fuller N., Rand R.P., St George-Hyslop P., and Fraser P.E. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein. J. Mol. Biol. 315 (2002) 799-807
33. Giannakis E., Pacifico J., Smith D.P., Hung L.W., Masters C.L., Cappai R., Wade J.D., and Barnham K.J. Dimeric structures of alpha-synuclein bind preferentially to lipid membranes. Biochim. Biophys. Acta 1778 (2008) 1112-1119
34. Chen L., and Feany M.B. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat. Neurosci. 8 (2005) 657-663
35. Anderson J.P., Walker D.E., Goldstein J.M., de Laat R., Banducci K., Caccavello R.J., Barbour R., Huang J., Kling K., Lee M., Diep L., Keim P.S., Shen X., Chataway T., Schlossmacher M.G., Seubert P., Schenk D., Sinha S., Gai W.P., and Chilcote T.J. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281 (2006) 29739-29752
36. Panek H.R., Stepp J.D., Engle H.M., Marks K.M., Tan P.K., Lemmon S.K., and Robinson L.C. Suppressors of YCK-encoded yeast casein kinase 1 deficiency define the four subunits of a novel clathrin AP-like complex. EMBO J. 16 (1997) 4194-4204
37. Marchal C., Haguenauer-Tsapis R., and Urban-Grimal D. Casein kinase I-dependent phosphorylation within a PEST sequence and ubiquitination at nearby lysines signal endocytosis of yeast uracil permease. J. Biol. Chem. 275 (2000) 23608-23614
38. Marchal C., Dupre S., and Urban-Grimal D. Casein kinase I controls a late step in the endocytic trafficking of yeast uracil permease. J. Cell Sci. 115 (2002) 217-226
39. Zhang B., and Zelhof A.C. Amphiphysins: raising the BAR for synaptic vesicle recycling and membrane dynamics. Bin-Amphiphysin-Rvsp. Traffic 3 (2002) 452-460
40. Dawson J.C., Legg J.A., and Machesky L.M. Bar domain proteins: a role in tubulation, scission and actin assembly in clathrin-mediated endocytosis. Trends Cell Biol. 16 (2006) 493-498
41. Breton A.M., Schaeffer J., and Aigle M. The yeast Rvs161 and Rvs167 proteins are involved in secretory vesicles targeting the plasma membrane and in cell integrity. Yeast 18 (2001) 1053-1068
42. Schoenebeck B., Bader V., Zhu X.R., Schmitz B., Lubbert H., and Stichel C.C. Sgk1, a cell survival response in neurodegenerative diseases. Mol. Cell Neurosci. 30 (2005) 249-264
43. Casamayor A., Torrance P.D., Kobayashi T., Thorner J., and Alessi D.R. Functional counterparts of mammalian protein kinases PDK1 and SGK in budding yeast. Curr. Biol. 9 (1999) 186-197
44. Roelants F.M., Torrance P.D., Bezman N., and Thorner J. Pkh1 and pkh2 differentially phosphorylate and activate ypk1 and ykr2 and define protein kinase modules required for maintenance of cell wall integrity. Mol. Biol. Cell 13 (2002) 3005-3028
45. Grosshans B.L., Grotsch H., Mukhopadhyay D., Fernandez I.M., Pfannstiel J., Idrissi F.Z., Lechner J., Riezman H., and Geli M.I. TEDS site phosphorylation of the yeast myosins I is required for ligand-induced but not for constitutive endocytosis of the G protein-coupled receptor Ste2p. J. Biol. Chem. 281 (2006) 11104-11114
46. Toret C.P., and Drubin D.G. The budding yeast endocytic pathway. J. Cell Sci. 119 (2006) 4585-4587
47. deHart A.K., Schnell J.D., Allen D.A., and Hicke L. The conserved Pkh-Ypk kinase cascade is required for endocytosis in yeast. J. Cell Biol. 156 (2002) 241-248
48. Aronova S., Wedaman K., Anderson S., Yates III J., and Powers T. Probing the membrane environment of the TOR kinases reveals functional interactions between TORC1, actin, and membrane trafficking in Saccharomyces cerevisiae. Mol. Biol. Cell 18 (2007) 2779-2794
49. Munn A.L., Heese-Peck A., Stevenson B.J., Pichler H., and Riezman H. Specific sterols required for the internalization step of endocytosis in yeast. Mol. Biol. Cell 10 (1999) 3943-3957
50. Heese-Peck A., Pichler H., Zanolari B., Watanabe R., Daum G., and Riezman H. Multiple functions of sterols in yeast endocytosis. Mol. Biol. Cell 13 (2002) 2664-2680
51. Gerrard S.R., Bryant N.J., and Stevens T.H. VPS21 controls entry of endocytosed and biosynthetic proteins into the yeast prevacuolar compartment. Mol. Biol. Cell 11 (2000) 613-626
52. Gerrard S.R., Levi B.P., and Stevens T.H. Pep12p is a multifunctional yeast syntaxin that controls entry of biosynthetic, endocytic and retrograde traffic into the prevacuolar compartment. Traffic 1 (2000) 259-269
53. Whyte J.R., and Munro S. Vesicle tethering complexes in membrane traffic. J. Cell Sci. 115 (2002) 2627-2637
54. Dupre S., and Haguenauer-Tsapis R. Deubiquitination step in the endocytic pathway of yeast plasma membrane proteins: crucial role of Doa4p ubiquitin isopeptidase. Mol. Cell Biol. 21 (2001) 4482-4494
55. Bryant N.J., Piper R.C., Gerrard S.R., and Stevens T.H. Traffic into the prevacuolar/endosomal compartment of Saccharomyces cerevisiae: a VPS45-dependent intracellular route and a VPS45-independent, endocytic route. Eur. J. Cell Biol. 76 (1998) 43-52
56. Abeliovich H., Darsow T., and Emr S.D. Cytoplasm to vacuole trafficking of aminopeptidase I requires a t-SNARE-Sec1p complex composed of Tlg2p and Vps45p. EMBO J. 18 (1999) 6005-6016
57. Nikko E., Marini A.M., and Andre B. Permease recycling and ubiquitination status reveal a particular role for Bro1 in the multivesicular body pathway. J. Biol. Chem. 278 (2003) 50732-50743
58. Bugnicourt A., Froissard M., Sereti K., Ulrich H.D., Haguenauer-Tsapis R., and Galan J.M. Antagonistic roles of ESCRT and Vps class C/HOPS complexes in the recycling of yeast membrane proteins. Mol. Biol. Cell 15 (2004) 4203-4214
59. Rubio-Texeira M., and Kaiser C.A. Amino acids regulate retrieval of the yeast general amino acid permease from the vacuolar targeting pathway. Mol. Biol. Cell 17 (2006) 3031-3050
60. Banta L.M., Vida T.A., Herman P.K., and Emr S.D. Characterization of yeast Vps33p, a protein required for vacuolar protein sorting and vacuole biogenesis. Mol. Cell Biol. 10 (1990) 4638-4649
61. Subramanian S., Woolford C.A., and Jones E.W. The Sec1/Munc18 protein, Vps33p, functions at the endosome and the vacuole of Saccharomyces cerevisiae. Mol. Biol. Cell 15 (2004) 2593-2605
62. Polevoda B., and Sherman F. N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. J. Mol. Biol. 325 (2003) 595-622
63. Song O.K., Wang X., Waterborg J.H., and Sternglanz R. An Nalpha-acetyltransferase responsible for acetylation of the N-terminal residues of histones H4 and H2A. J. Biol. Chem. 278 (2003) 38109-38112
64. Hermann G.J., King E.J., and Shaw J.M. The yeast gene, MDM20, is necessary for mitochondrial inheritance and organization of the actin cytoskeleton. J. Cell Biol. 137 (1997) 141-153
65. Singer J.M., and Shaw J.M. Mdm20 protein functions with Nat3 protein to acetylate Tpm1 protein and regulate tropomyosin-actin interactions in budding yeast. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7644-7649
66. Polevoda B., Cardillo T.S., Doyle T.C., Bedi G.S., and Sherman F. Nat3p and Mdm20p are required for function of yeast NatB Nalpha-terminal acetyltransferase and of actin and tropomyosin. J. Biol. Chem. 278 (2003) 30686-30697
67. Caesar R., Warringer J., and Blomberg A. Physiological importance and identification of novel targets for the N-terminal acetyltransferase NatB. Eukaryot. Cell 5 (2006) 368-378
68. Fortin D.L., Troyer M.D., Nakamura K., Kubo S., Anthony M.D., and Edwards R.H. Lipid rafts mediate the synaptic localization of alpha-synuclein. J. Neurosci. 24 (2004) 6715-6723
69. Pike L.J. Lipid rafts: heterogeneity on the high seas. Biochem. J. 378 (2004) 281-292
70. Palermo L.M., Leak F.W., Tove S., and Parks L.W. Assessment of the essentiality of ERG genes late in ergosterol biosynthesis in Saccharomyces cerevisiae. Curr. Genet. 32 (1997) 93-99
71. Mo C., and Bard M. Erg28p is a key protein in the yeast sterol biosynthetic enzyme complex. J. Lipid. Res. 46 (2005) 1991-1998
72. Bar-On P., Rockenstein E., Adame A., Ho G., Hashimoto M., and Masliah E. Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy. J. Neurochem. 98 (2006) 1032-1045
73. Gaigg B., Timischl B., Corbino L., and Schneiter R. Synthesis of sphingolipids with very long chain fatty acids but not ergosterol is required for routing of newly synthesized plasma membrane ATPase to the cell surface of yeast. J. Biol. Chem. 280 (2005) 22515-22522
74. Lauwers E., and Andre B. Association of yeast transporters with detergent-resistant membranes correlates with their cell-surface location. Traffic 7 (2006) 1045-1059
75. Ihara M., Yamasaki N., Hagiwara A., Tanigaki A., Kitano A., Hikawa R., Tomimoto H., Noda M., Takanashi M., Mori H., Hattori N., Miyakawa T., and Kinoshita M. Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity. Neuron 53 (2007) 519-533
76. Spencer B., Crews L., and Masliah E. Climbing the scaffolds of Parkinson's disease pathogenesis. Neuron 53 (2007) 469-470
77. Hicke L. Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends Cell Biol. 9 (1999) 107-112
78. Gadura N., Robinson L.C., and Michels C.A. Glc7-Reg1 phosphatase signals to Yck1,2 casein kinase 1 to regulate transport activity and glucose-induced inactivation of Saccharomyces maltose permease. Genetics 172 (2006) 1427-1439
79. Moriya H., and Johnston M. Glucose sensing and signaling in Saccharomyces cerevisiae through the Rgt2 glucose sensor and casein kinase I. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 1572-1577
80. Meriin A.B., Zhang X., Alexandrov I.M., Salnikova A.B., Ter-Avanesian M.D., Chernoff Y.O., and Sherman M.Y. Endocytosis machinery is involved in aggregation of proteins with expanded polyglutamine domains. FASEB J. 21 (2007) 1915-1925
81. Meriin A.B., Zhang X., Miliaras N.B., Kazantsev A., Chernoff Y.O., McCaffery J.M., Wendland B., and Sherman M.Y. Aggregation of expanded polyglutamine domain in yeast leads to defects in endocytosis. Mol. Cell Biol. 23 (2003) 7554-7565
82. Flower T.R., Clark-Dixon C., Metoyer C., Yang H., Shi R., Zhang Z., and Witt S.N. YGR198w (YPP1) targets A30P {alpha}-synuclein to the vacuole for degradation. J. Cell Biol. 177 (2007) 1091-1104
83. Dupre S., and Haguenauer-Tsapis R. Raft partitioning of the yeast uracil permease during trafficking along the endocytic pathway. Traffic 4 (2003) 83-96
84. Kobayashi T., Gu F., and Gruenberg J. Lipids, lipid domains and lipid-protein interactions in endocytic membrane traffic. Semin. Cell Dev. Biol. 9 (1998) 517-526
85. Simons K., and Gruenberg J. Jamming the endosomal system: lipid rafts and lysosomal storage diseases. Trends Cell Biol. 10 (2000) 459-462
86. Ungermann C., von Mollard G.F., Jensen O.N., Margolis N., Stevens T.H., and Wickner W. Three v-SNAREs and two t-SNAREs, present in a pentameric cis-SNARE complex on isolated vacuoles, are essential for homotypic fusion. J. Cell Biol. 145 (1999) 1435-1442
87. Dietrich L.E., Peplowska K., LaGrassa T.J., Hou H., Rohde J., and Ungermann C. The SNARE Ykt6 is released from yeast vacuoles during an early stage of fusion. EMBO Rep. 6 (2005) 245-250
88. Kweon Y., Rothe A., Conibear E., and Stevens T.H. Ykt6p is a multifunctional yeast R-SNARE that is required for multiple membrane transport pathways to the vacuole. Mol. Biol. Cell 14 (2003) 1868-1881
89. Lee F.J., Lin L.W., and Smith J.A. Identification of methionine Nalpha-acetyltransferase from Saccharomyces cerevisiae. J. Biol. Chem. 265 (1990) 3603-3606
90. Vetting M.W., de Carvalho LP S., Yu M., Hegde S.S., Magnet S., Roderick S.L., and Blanchard J.S. Structure and functions of the GNAT superfamily of acetyltransferases. Arch. Biochem. Biophys. 433 (2005) 212-226
91. Volles M.J., and Lansbury Jr. P.T. Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity. J. Mol. Biol. 366 (2007) 1510-1522
92. Brandis K.A., Holmes I.F., England S.J., Sharma N., Kukreja L., and DebBurman S.K. alpha-Synuclein fission yeast model: concentration-dependent aggregation without plasma membrane localization or toxicity. J. Mol. Neurosci. 28 (2006) 179-191